Sanger’s Sequencing Service Market Overview:

The Global Sanger’s Sequencing Service Market was valued at $192 million in 2013, and is estimated to reach at $1,085 million by 2025, registering a CAGR of 14.2% from 2018 to 2025. Sanger’s sequencing is one of the most pivotal techniques used by molecular biologists worldwide for sequence analysis. In this method, the target nucleic acid is reproduced several times, thereby making fragments of varying lengths.

Technological advancements in sequencing procedures, advantages associated with Sanger’s sequencing, and increase in genome mapping programs boost the growth of the global Sanger’s sequencing services market. Furthermore, rise in investment in R&D and increase in sequencing applications have supplemented the market growth.

However, lack of skilled professionals and standardization concerns associated with sequencing procedures hamper the growth of the industry. On the contrary, untapped potential of emerging markets and the use of cloud computing as a potential data management service are expected to provide lucrative opportunities for the market expansion.

The Sanger’s sequencing service market is segmented based on application, end user, and region. On the basis of application, the market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and others. By end user, it is categorized into academic & government research institutes, pharmaceuticals companies, biotechnology companies and hospitals & clinics. Region wise, it is analyzed across the U.S., Europe, Japan, China, India, South-East Asia, and rest of the world (ROW).

       Get more information on this report : Request Sample Pages

The Sanger’s sequencing market share is dominated by the biomarkers & cancer segment, owing to their wide application in oncology research, biomarker discovery, and surge in prevalence of chronic diseases such as cancer.

Get more information on this report : Request Sample Pages

Rise in focus of vendors on emerging markets, such as China, India, and Southeast Asia is expected to boost the market growth. China is projected to witness significant growth in the near future, owing to increase in R&D investment and surge in applications of Sanger’s sequencing. Furthermore, the Chinese region presents noteworthy opportunities for the venture capitalists and investors, as the developed markets are comparatively saturated.

The report provides extensive competitive analysis and profiles of the key market players such as Source BioScience, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., LGC Science Group Limited, Fasteris SA, CeMIA SA, Quintara Biosciences, GenHunter Corporation, GENEWIZ, Nucleics, SciGenom Labs Pvt. Limited, and Microsynth AG. Inc. The other players in the value chain (not included in the report) include Laragen, Inc. and StarSEQ GmbH.

Key Benefits for Stakeholders

• This report entails a detailed quantitative analysis of the current market trends from 2013 to 2025 to identify the prevailing opportunities along with strategic assessment of global Sanger’s sequencing service market.
• Sanger’s sequencing service market size and market estimations are based on comprehensive analysis of the applications, end users, and developments in the industry.
• In-depth analysis based on region assists to understand the regional market and the strategic business planning.
• The development strategies adopted by key market players are enlisted to understand the competitive scenario of the market.

 Key Market Segments

• By Application
  • Diagnostics
  • Biomarkers & Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Others
• By End User
  • Academic & Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals & Clinics
• By Region
  • U.S.
  • Europe
  • Japan
  • China
  • India
  • Southeast Asia
  • Rest of the World

 
Key Market Players

• Fasteris SA
• GENEWIZ, Inc.
• GenHunter Corporation
• Source BioScience Plc
• Nucleics Pty. Ltd.
• CeMIA SA
• Thermo Fisher Scientific Inc.
• Genscript Biotech Corporation
• Microsynth AG
• LGC Science Group Holdings Limited
• SciGenom Labs Pvt. Ltd.
• Quintara Biosciences

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market scope and definition
3.2. Competitive environment analysis

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Top player positioning, 2016
3.4. Patent analysis, 2010-2018
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Technological advancements in Sanger's sequencing
3.5.1.2. Surge in applications of Sanger's sequencing
3.5.1.3. Increase in genome mapping programs

3.5.2. Restraints

3.5.2.1. Lack of skilled professionals
3.5.2.2. Standardization concerns over sequencing-based diagnostics

3.5.3. Opportunities

3.5.3.1. Cloud computing serves as a potential data management service
3.5.3.2. Lucrative opportunities in the emerging markets

CHAPTER 4: GLOBAL AND REGIONAL Sanger's SEQUENCING SERVICE MARKET SHARE ANALYSIS

4.1. Global Sanger's sequencing services market share analysis, 2017
4.2. U.S. Sanger's sequencing services market share analysis, 2017
4.3. Europe Sanger's sequencing services market share analysis, 2017
4.4. Japan Sanger's sequencing services market share analysis, 2017
4.5. China Sanger's sequencing services market share analysis, 2017
4.6. India Sanger's sequencing services market share analysis, 2017
4.7. South-East Asia Sanger's sequencing services market share analysis, 2017
4.8. Rest of the world Sanger's sequencing services market share analysis, 2017

CHAPTER 5: GLOBAL Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Diagnostics

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by region

5.3. Biomarkers & cancer

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by region

5.4. Reproductive health

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by region

5.5. Personalized medicine

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by region

5.6. Forensics

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by region

5.7. Others

5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by region

CHAPTER 6: GLOBAL Sanger's SEQUENCING SERVICE MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Academic & government research institutes

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by region

6.3. Pharmaceutical companies

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by region

6.4. Biotechnology companies

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by region

6.5. Hospitals & clinics

6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by region

CHAPTER 7: GLOBAL Sanger's SEQUENCING SERVICE MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. U.S.

7.2.1. Key market trends
7.2.2. U.S. market size and forecast

7.2.2.1. U.S. Sanger's sequencing service market, by application
7.2.2.2. U.S. Sanger's sequencing service market, by end user

7.3. Europe

7.3.1. Key market trends
7.3.2. Europe market size and forecast

7.3.2.1. Europe Sanger's sequencing service market, by application
7.3.2.2. Europe Sanger's sequencing service market, by end user

7.4. Japan

7.4.1. Key market trends
7.4.2. Japan market size and forecast

7.4.2.1. Japan Sanger's sequencing service market, by application
7.4.2.2. Japan Sanger's sequencing service market, by end user

7.5. China

7.5.1. Key market trends
7.5.2. China market size and forecast

7.5.2.1. China Sanger's sequencing service market, by application
7.5.2.2. China Sanger's sequencing service market, by end user

7.6. India

7.6.1. Key market trends
7.6.2. India market size and forecast

7.6.2.1. India Sanger's sequencing service market, by application
7.6.2.2. India Sanger's sequencing service market, by end user

7.7. Southeast Asia

7.7.1. Key market trends
7.7.2. Southeast Asia market size and forecast

7.7.2.1. Southeast Asia Sanger's sequencing service market, by application
7.7.2.2. Southeast Asia Sanger's sequencing service market, by end user

7.8. Rest of the world

7.8.1. Key market trends
7.8.2. Rest of the world market size and forecast

7.8.2.1. Rest of the world Sanger's sequencing service market, by application
7.8.2.2. Rest of the world Sanger's sequencing service market, by end user

CHAPTER 8: COMPANY PROFILES

8.1. CeMIA SA

8.1.1. Company Profile
8.1.2. Main business/business overview
8.1.3. Products, services, and solutions
8.1.4. CeMIA Revenue (Million USD)

8.2. Fasteris SA

8.2.1. Company Profile
8.2.2. Main business/business overview
8.2.3. Products, Services, and Solutions
8.2.4. Fasteris revenue (million USD)

8.3. GENEWIZ, Inc.

8.3.1. Company Profile
8.3.2. Main business/business overview
8.3.3. Products, services, and solutions
8.3.4. GENEWIZ Revenue (Million USD)
8.3.5. Recent developments

8.4. GenHunter Corporation

8.4.1. Company Profile
8.4.2. Main business/business overview
8.4.3. Products, Services, and Solutions
8.4.4. GenHunter revenue (million USD)

8.5. Genscript Biotech Corporation

8.5.1. Company Profile
8.5.2. Main Business/Business Overview
8.5.3. Products, Services, and Solutions
8.5.4. GenScript revenue (million USD)

8.6. LGC Science Group Holdings Limited

8.6.1. Company Profile
8.6.2. Main Business/Business Overview
8.6.3. Products, Services, and Solutions
8.6.4. LGC revenue (million USD)
8.6.5. Recent developments

8.7. Microsynth AG

8.7.1. Company Profile
8.7.2. Main business/business overview
8.7.3. Products, Services, and Solutions
8.7.4. Microsynth revenue (million USD)

8.8. Nucleics Pty. Ltd.

8.8.1. Company Profile
8.8.2. Main Business/Business Overview
8.8.3. Products, Services, and Solutions
8.8.4. Nucleics revenue (million USD)

8.9. Quintara Biosciences

8.9.1. Company Profile
8.9.2. Main Business/Business Overview
8.9.3. Products, Services, and Solutions
8.9.4. Quintara revenue (million USD)
8.9.5. Recent Developments

8.10. SciGenom Labs Pvt. Ltd.

8.10.1. Company Profile
8.10.2. Main business/business overview
8.10.3. Products, Services, and Solutions
8.10.4. SciGenom Labs revenue (million USD)

8.11. Source BioScience Plc

8.11.1. Company Profile
8.11.2. Main business/business overview
8.11.3. Products, services, and solutions
8.11.4. Source BioScience revenue (million USD)

8.12. Thermo Fisher Scientific Inc.

8.12.1. Company Profile
8.12.2. Main business/business overview
8.12.3. Products, services, and solutions
8.12.4. Thermo Fisher revenue (million USD)
8.12.5. Recent developments

LIST OF TABLES

TABLE 01. GLOBAL Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 02. Sanger's SEQUENCING SERVICE MARKET FOR DIAGNOSTICS, BY REGION, 2013-2025 ($MILLION)
TABLE 03. Sanger's SEQUENCING SERVICE MARKET FOR BIOMARKERS & CANCER, BY REGION, 2013-2025 ($MILLION)
TABLE 04. Sanger's SEQUENCING SERVICE MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2013-2025 ($MILLION)
TABLE 05. Sanger's SEQUENCING SERVICE MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2013-2025 ($MILLION)
TABLE 06. Sanger's SEQUENCING SERVICE MARKET FOR FORENSICS, BY REGION, 2013-2025 ($MILLION)
TABLE 07. Sanger's SEQUENCING SERVICE MARKET FOR OTHERS, BY REGION, 2013-2025 ($MILLION)
TABLE 08. GLOBAL Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 09. Sanger's SEQUENCING SERVICE MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2013-2025 ($MILLION)
TABLE 10. Sanger's SEQUENCING SERVICE MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2013-2025 ($MILLION)
TABLE 11. Sanger's SEQUENCING SERVICE MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2025 ($MILLION)
TABLE 12. Sanger's SEQUENCING SERVICE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2013-2025 ($MILLION)
TABLE 13. Sanger's SEQUENCING SERVICE MARKET, BY REGION, 2013-2025 ($MILLION)
TABLE 14. U.S. Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 15. U.S. Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 16. Europe Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 17. Europe Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 18. JAPAN Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 19. JAPAN Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 20. CHINA Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 21. CHINA Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 22. INDIA Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 23. INDIA Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 24. SOUTHEAST ASIA Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 25. SOUTHEAST ASIA Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 26. REST OF THE WORLD Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 27. REST OF THE WORLD Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 28. CEMIA: COMPANY SNAPSHOT
TABLE 29. FASTERIS: COMPANY SNAPSHOT
TABLE 30. GENEWIZ: COMPANY SNAPSHOT
TABLE 31. GENHUNTER: COMPANY SNAPSHOT
TABLE 32. GENSCRIPT: COMPANY SNAPSHOT
TABLE 33. LGC: COMPANY SNAPSHOT
TABLE 34. MICROSYNTH: COMPANY SNAPSHOT
TABLE 35. NUCLEICS: COMPANY SNAPSHOT
TABLE 36. QUINTARA: COMPANY SNAPSHOT
TABLE 37. SCIGENOM LABS: COMPANY SNAPSHOT
TABLE 38. SOURCE BIOSCIENCE: COMPANY SNAPSHOT
TABLE 39. THERMO FISHER: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 01. GLOBAL Sanger's SEQUENCING SERVICE MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2014-2017
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2014-2017 (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2017
FIGURE 06. TOP PLAYER POSITIONING, 2016
FIGURE 07. PATENT ANALYSIS, BY YEAR
FIGURE 08. PATENT ANALYSIS, BY REGION
FIGURE 09. GLOBAL Sanger's SEQUENCING SERVICE MARKET: IMPACT ANALYSES
FIGURE 10. GLOBAL Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 11. U.S. Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 12. Europe Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 13. JAPAN Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 14. CHINA Sanger's SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2017
FIGURE 15. INDIA Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 16. SOUTH-EAST ASIA Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 17. REST OF THE WORLD Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 18. GLOBAL Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION
FIGURE 19. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR DIAGNOSTICS, 2013 AND 2025 ($MILLION)
FIGURE 20. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR BIOMARKERS & CANCER, 2013 AND 2025 ($MILLION)
FIGURE 21. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR REPRODUCTIVE HEALTH, 2013 AND 2025 ($MILLION)
FIGURE 22. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR PERSONALIZED MEDICINE, 2013 AND 2025 ($MILLION)
FIGURE 23. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR FORENSICS, 2013 AND 2025 ($MILLION)
FIGURE 24. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR OTHERS, 2013 AND 2025 ($MILLION)
FIGURE 25. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2013 AND 2025 ($MILLION)
FIGURE 26. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR PHARMACEUTICAL COMPANIES, 2013 AND 2025 ($MILLION)
FIGURE 27. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR BIOTECHNOLOGY COMPANIES, 2013 AND 2025 ($MILLION)
FIGURE 28. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR HOSPITALS & CLINICS, 2013 AND 2025 ($MILLION)
FIGURE 29. GENSCRIPT: NET SALES, 2014-2016 ($MILLION)
FIGURE 30. GENSCRIPT: REVENUE SHARE BY SEGMENT, 2017 ($MILLION)
FIGURE 31. GENSCRIPT: REVENUE SHARE BY GEOGRAPHY, 2017 ($MILLION)
FIGURE 32. LGC: NET SALES, 2014-2017 ($MILLION)
FIGURE 33. SOURCE BIOSCIENCE: NET SALES, 2013-2015 ($MILLION)
FIGURE 34. SOURCE BIOSCIENCE : REVENUE SHARE BY DIVISION, 2015 ($MILLION)
FIGURE 35. THERMO FISHER: NET SALES, 2015-2017 ($MILLION)
FIGURE 36. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2017 ($MILLION)
FIGURE 37. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2017 ($MILLION)